Acamprosate 333mg gastro-resistant tablets

Land: Verenigd Koninkrijk

Taal: Engels

Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)

Werkstoffen:

Acamprosate calcium

Beschikbaar vanaf:

Viatris UK Healthcare Ltd

ATC-code:

N07BB03

INN (Algemene Internationale Benaming):

Acamprosate calcium

Dosering:

333mg

farmaceutische vorm:

Gastro-resistant tablet

Toedieningsweg:

Oral

klasse:

No Controlled Drug Status

Prescription-type:

Valid as a prescribable product

Product samenvatting:

BNF: 04100100; GTIN: 5016695003986

Bijsluiter

Myriad Pro
10.5 pt
10.5 pt
Acamprosate_333mg_168
Leaflet
1936962
N/A
1936962
PL 04569/1610
Mylan Laboratories
Ltd (Aurangabad - IN)
75068816
TBC
N/A
102864316/0020
3
United Kingdom
KLD_Acamprosate Tabs 333mg_
Leaflet (Blister Pack)_170 x 320mm
N/A
1
170 x 320 mm
BLACK
1 / 2
N/A
v3/Jul 2017
Colours
Non-Print
Colours
Date:
Time:
Equate CMYK
with
Dimensions
Main Font
Body Text Size
Min Text Size used
Page Count
No. of colours
Pharma Code
SAP No.
Vendor Job No.
Trackwise Proof No.
Client Market
Keyline/Drawing No.
Barcode Info
Description
Component Type
Superceded Affiliate Item Code
TrackWise PR No.
MA No.
Packing Site/Printer
Supplier Code
Sign-offs
Affiliate Item Code
3D Render ID
15:57
19 Sep 19
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ACAMPROSATE 333 MG
GASTRO-RESISTANT TABLETS
acamprosate calcium
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read
it again.
•
If you have any further questions, ask your
doctor or pharmacist.
•
This medicine has been prescribed for you
only. Do not pass it on to others. It may
harm them, even if their signs of illness are
the same as yours.
•
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET
1.
What Acamprosate is and what it is used for
2.
What you need to know before you take
Acamprosate
3.
How to take Acamprosate
4.
Possible side effects
5.
How to store Acamprosate
6.
Contents of the pack and other information
1. WHAT ACAMPROSATE IS AND WHAT IT IS
USED FOR
Acamprosate is a medicine which acts on the
central nervous system (the brain and the
spinal cord).
Acamprosate is used for the treatment of alcohol
dependence. It helps to maintain abstinence in
alcohol-dependent patients.
Acamprosate in combination with counselling
will help you to not drink alcohol. It does this by
acting on the chemical changes that have taken
place in the bra

Productkenmerken

OBJECT 1
ACAMPROSATE 333 MG GASTRO-RESISTANT TABLETS.
Summary of Product Characteristics Updated 28-Jun-2017 | Generics UK
T/A Mylan
1. Name of the medicinal product
Acamprosate 333 mg Gastro-resistant Tablets.
2. Qualitative and quantitative composition
Each gastro-resistant tablet contains acamprosate calcium 333.0 mg as
the active ingredient.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Gastro-resistant tablet.
White, round, biconvex coated tablet with “M” over “AC”
printed in black ink on one side of the tablet
and blank on the other side.
4. Clinical particulars
4.1 Therapeutic indications
Acamprosate is indicated as therapy to maintain abstinence in
alcohol-dependent patients. It should be
combined with counselling.
4.2 Posology and method of administration
Posology
_Adults within the age range 18-65 years_
- 2 tablets three times daily with meals (2 tablets in the morning,
noon and night) in subjects weighing
60kg or more.
- In subjects weighing less than 60kg, 4 tablets divided into three
daily doses with meals (2 tablets in the
morning, 1 at noon and 1 at night).
_Paediatric population and older people_
Acamprosate should not be administered to children, adolescents and
the elderly.
_Duration of treatment_
The recommended treatment period is one year. Treatment with
acamprosate should be initiated as soon
as possible after the withdrawal period and should be maintained if
the patient relapses.
Acamprosate does not prevent the harmful effects of continuous alcohol
abuse. Continued alcohol abuse
negates the therapeutic benefit; therefore acamprosate treatment
should only be initiated after weaning
therapy, once the patient is abstinent from alcohol.
Method of administration
For oral use.
Swallow this tablet whole. Do not chew or crush the tablet as this may
damage the gastro-resistant
coating.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1. Breast-feeding
women (see section 4.6)
Patients with renal impairm